John Park

John Park is a Conjoint Senior Lecturer at Macquarie Medical School and a Medical Oncologist affiliated with Macquarie University Clinical Associates (MUCA). His primary affiliation is with Macquarie University, where he contributes to both clinical and academic activities in oncology.

Research Interests: Dr. Park focuses on advanced melanoma treatment strategies, immunotherapy efficacy, drug development for solid tumors, and molecular mechanisms of cancer resistance. His work spans clinical trials (Phase I/II) and translational research in targeted therapies, including antibody-drug conjugates and HER2-directed treatments.

Publications: His recent work emphasizes survival analysis in melanoma patients, immune-checkpoint inhibitors for squamous cell carcinoma, and molecular signaling pathways in uveal melanoma. Over 34 research outputs since 2010 reflect a strong publication record in oncology.

Grants & Advising: Active in securing research grants (e.g., Beamion PANTUMOR-1 trial funding) and collaborates with global teams on drug development. No formal advisee list is provided in the current data.

Labs/Teams: Engaged with multidisciplinary teams in clinical oncology and translational medicine through MUCA and Macquarie Medical School collaborations.